PMID: 18711156Aug 20, 2008Paper

Narrative review: furosemide for hypercalcemia: an unproven yet common practice

Annals of Internal Medicine
Susan B LeGrandIvan Zama

Abstract

Although primary hyperparathyroidism is the most common cause of hypercalcemia, cancer is the most common cause requiring inpatient intervention. An estimated 10% to 20% of all patients with cancer have hypercalcemia at some point in their disease trajectory, particularly in advanced disease. Aggressive saline hydration and varying doses of furosemide continue to be the standard of care for emergency management. However, a review of the evidence for the use of furosemide in the medical management of hypercalcemia yields only case reports published before the introduction of bisphosphonates, in contrast to multiple randomized, controlled trials supporting the use of bisphosphonates. The use of furosemide in the management of hypercalcemia should no longer be recommended.

Citations

Sep 29, 2011·QJM : Monthly Journal of the Association of Physicians·Y-G ChenP-J Chen
May 18, 2011·Current Opinion in Pulmonary Medicine·Sai-Ching J YeungSonali N Thosani
Apr 6, 2012·Southern Medical Journal·Sarah FrenchStephen Geraci
Oct 1, 2010·Therapeutic Advances in Endocrinology and Metabolism·Richard Carroll, Glenn Matfin
Jun 14, 2013·Clinical Medicine : Journal of the Royal College of Physicians of London·Rachel Crowley, Neil Gittoes
Feb 23, 2013·Case Reports in Emergency Medicine·Simon C WatsonLancer A Scott
Jul 26, 2014·Emergency Medicine Clinics of North America·Jonathan Wagner, Sanjay Arora
Sep 12, 2014·International Journal of Clinical Pharmacy·David AttiviStéphane Gibaud
Aug 13, 2013·Der Internist·O HopferM G Kiehl
Jan 29, 2016·Advanced Emergency Nursing Journal·Bethany Dellay, Meghan Groth
Dec 24, 2013·Advances in Chronic Kidney Disease·Mitchell H Rosner, Alan C Dalkin
Sep 12, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Patrick ReaganMitchell H Rosner
Jul 28, 2015·American Journal of Hematology·Wilson I GonsalvesLuciano J Costa
Aug 28, 2012·Advances in Chronic Kidney Disease·Nelson Leung, Judith Behrens
Jan 15, 2016·Mayo Clinic Proceedings·Heather M Klingeman, Ann E Kearns
Nov 22, 2011·Seminars in Nephrology·Marvin Grieff, David A Bushinsky
Dec 4, 2009·Mayo Clinic Proceedings·D Brian NewmanThomas J Beckman
Aug 19, 2009·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Husam G EliasFaisal A Quereshy
Sep 26, 2015·Future Oncology·Sonali Thosani, Mimi I Hu
Dec 30, 2015·North American Journal of Medical Sciences·Aibek E Mirrakhimov
Dec 17, 2009·Acta Clinica Belgica·K Van den HauweW A Buylaert
Apr 10, 2010·British Journal of Haematology·Jeremy T S Sargent, Owen P Smith
Jan 28, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Kimberly UlettRobert Centor
May 16, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ingo J DielAda Braun
Aug 27, 2013·Orvosi hetilap·Ildikó RadványiSándor Balogh
May 14, 2016·Journal of Oncology Practice·Whitney Goldner
May 4, 2017·The New England Journal of Medicine·Mitchell H Rosner, Mark A Perazella
Jun 2, 2017·Continuum : Lifelong Learning in Neurology·Makoto Ishii
Apr 8, 2017·Mayo Clinic Proceedings·Thorvardur R HalfdanarsonBo E Madsen
Oct 17, 2013·Journal of Intensive Care Medicine·Joshua D Maier, Steven N Levine
Mar 6, 2013·Journal of Pharmacy Practice·Suzanna Gim, William R Vincent
Oct 5, 2017·Archives of Endocrinology and Metabolism·Hernan Valdes-SocinAlbert Beckers
Jul 5, 2011·The American Journal of Hospice & Palliative Care·Susan B Legrand
Oct 13, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Kelly PlachKatherine Shea
Sep 22, 2018·CA: a Cancer Journal for Clinicians·Jonathan ZagzagNancy D Perrier
Mar 12, 2019·Journal of Pharmacy Practice·Judith Jacobi
Aug 11, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Mitchell H Rosner, Alan C Dalkin
Aug 6, 2013·Current Opinion in Supportive and Palliative Care·Nazanin Fallah-Rad, A Ross Morton
Sep 8, 2011·Current Opinion in Endocrinology, Diabetes, and Obesity·Gregory A Clines
Nov 26, 2013·International Journal of Palliative Nursing·Annie Pettifer, Sarah Grant
Jun 11, 2014·The Journal of Clinical Endocrinology and Metabolism·Mimi I HuRajul K Jain
Sep 28, 2017·Current Opinion in Critical Care·Mitchell H RosnerMark A Perazella
Jun 16, 2017·International Journal of Clinical Practice·Carla Rodriguez-CilleroAlain Putot
Jul 10, 2019·Kidney Research and Clinical Practice·Mitchell H Rosner, Mark A Perazella
Aug 28, 2020·CA: a Cancer Journal for Clinicians·Mitchell H RosnerMark A Perazella
May 26, 2017·Journal of Intensive Care Medicine·Maryam I KhanSteven G Waguespack
Jun 14, 2017·International Journal of Clinical Pharmacy·Abdulrazaq S Al-Jazairi, Reem Alharbi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Andrew F Stewart
The New England Journal of Medicine
H J Adrogué, N E Madias
The New England Journal of Medicine
J P Bilezikian
The American Journal of Medicine
Joseph G VerbalisRichard H Sterns
© 2022 Meta ULC. All rights reserved